← back to search

Marcel G. M. Olde Rikkert

Phoenix Contact (United States) · US
Area of research
Health, Toxicology and Mutagenesis · Psychiatry and Mental health
Research interest
Research interests include Dementia and Cognitive Impairment Research, Climate Change and Health Impacts, Air Quality and Health Impacts, and Nuclear Issues and Defense.
h-index
84
citations
37,106
works
1,084
NIH funding
primary concept
email

Recent publications

A complex systems approach to aging biology
Nature Aging 2022cited by 201position: middledoi
<scp>COVID</scp>‐19: immunopathology, pathophysiological mechanisms, and treatment options
The Journal of Pathology 2021cited by 149position: middledoi
Characteristics of subjective cognitive decline associated with amyloid positivity
Alzheimer s & Dementia 2021cited by 54position: middledoi
Lack of consensus on an aging biology paradigm? A global survey reveals an agreement to disagree, and the need for an interdisciplinary framework
Mechanisms of Ageing and Development 2020cited by 133position: middledoi
The conundrum of human immune system “senescence”
Mechanisms of Ageing and Development 2020cited by 118position: middledoi
Falls Risk in Relation to Activity Exposure in High-Risk Older Adults
The Journals of Gerontology Series A 2020cited by 84position: middledoi
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype
Alzheimer s & Dementia 2019cited by 559position: middledoi
Survival time tool to guide care planning in people with dementia
Neurology 2019cited by 121position: middledoi
The Association of Sedentary Behaviour and Cognitive Function in People Without Dementia: A Coordinated Analysis Across Five Cohort Studies from COSMIC
Sports Medicine 2019cited by 85position: middledoi
Quantifying resilience of humans and other animals
Proceedings of the National Academy of Sciences 2018cited by 373position: lastdoi
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
PLoS Medicine 2018cited by 200position: middledoi
The Impact of Frailty and Comorbidity on Institutionalization and Mortality in Persons With Dementia: A Prospective Cohort Study
Journal of the American Medical Directors Association 2018cited by 52position: middledoi
Comorbidity and progression of late onset Alzheimer’s disease: A systematic review
PLoS ONE 2017cited by 95position: middledoi
Recommendations for the Use of Serious Games in Neurodegenerative Disorders: 2016 Delphi Panel
Frontiers in Psychology 2017cited by 83position: middledoi
Association Between Later Life Lifestyle Factors and Alzheimer’s Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study
Journal of Alzheimer s Disease 2017cited by 58position: middledoi
Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning
Alzheimer s Research & Therapy 2017cited by 41position: middledoi
Defeating Alzheimer's disease and other dementias: a priority for European science and society
The Lancet Neurology 2016cited by 1,679position: middledoi
Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial
The Lancet 2016cited by 481position: middledoi
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people
Cochrane Database of Systematic Reviews 2015cited by 216position: middledoi
Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer’s dementia
Journal of Clinical and Experimental Neuropsychology 2015cited by 49position: middledoi
The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?
Alzheimer s & Dementia 2014cited by 307position: middledoi
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey
Alzheimer s & Dementia 2014cited by 74position: middledoi
Validation of the Care-Related Quality of Life Instrument in different study settings: findings from The Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS)
Quality of Life Research 2014cited by 49position: middledoi
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease
BMJ Open 2014cited by 45position: lastdoi
Frailty in elderly people
The Lancet 2013cited by 9,191position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

René J. F. Melis · Radboud University Nijmegen6 papers (2014–2019)Pieter Jelle Visser · Karolinska Institutet3 papers (2014–2019)Wiesje M. van der Flier · Alzheimer Nederland3 papers (2014–2019)Frans R.J. Verhey · Transnational University Limburg3 papers (2017–2019)Miriam L. Haaksma · Leiden University Medical Center3 papers (2017–2019)Philip Scheltens · University Hospital Cologne3 papers (2014–2019)Alice Nieuwboer · Neuroelectronics Research Flanders2 papers (2016–2020)Alan A. Cohen · Bühler (United Kingdom)2 papers (2020–2022)Bastiaan R. Bloem · University of Lausanne2 papers (2016–2020)Tamàs Fülöp · National University of Singapore2 papers (2020–2022)Luigi Ferrucci · Banyan Biomarkers (United States)2 papers (2020–2022)Debora Rizzuto · Stockholm University2 papers (2018–2019)Alessandra Marengoni · Stockholm University2 papers (2017–2018)Silvia Del Din · University of Padua2 papers (2016–2020)Lynn Rochester · Newcastle upon Tyne Hospitals NHS Foundation Trust2 papers (2016–2020)Anat Mirelman · Columbia University2 papers (2016–2020)Esther Bekkers · KU Leuven2 papers (2016–2020)Henrik Zetterberg · Indian Institute of Science Bangalore2 papers (2014–2019)Hilkka Soininen · Charles University2 papers (2017–2019)Jeannie‐Marie Leoutsakos · Johns Hopkins University2 papers (2017–2019)